Your browser doesn't support javascript.
loading
Recurrence rates of de-novo versus inverted papilloma-transformed sinonasal squamous cell carcinoma: a meta-analysis.
Birkenbeuel, J L; Goshtasbi, K; Adappa, N D; Palmer, J N; Tong, C C L; Kuan, E C.
Afiliação
  • Birkenbeuel JL; Department of Otolaryngology - Head and Neck Surgery, University of California, Irvine, CA, USA.
  • Goshtasbi K; Department of Otolaryngology - Head and Neck Surgery, University of California, Irvine, CA, USA.
  • Adappa ND; Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
  • Palmer JN; Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
  • Tong CCL; Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
  • Kuan EC; Department of Otolaryngology - Head and Neck Surgery, University of California, Irvine, CA, USA.
Rhinology ; 60(6): 402-410, 2022 Dec 01.
Article em En | MEDLINE | ID: mdl-36150160
ABSTRACT

BACKGROUND:

There is a paucity of reporting on recurrence patterns of de-novo sinonasal squamous cell carcinoma (DN-SCC) and inverted-papilloma-transformed sinonasal squamous cell carcinoma (IP-SCC).

METHOD:

A systematic literature review queried studies comparing recurrence patterns in patients with both DN-SCC and IP-SCC. Primary outcomes included local and regional recurrence and rates of distant metastasis. Of the 595 studies screened, eight were included.

RESULTS:

Patients with DN-SCC had significantly higher rates of positive margins, advanced T classification (T3/T4), treatment with chemotherapy and radiotherapy. There were no significant differences in local recurrence or regional recurrence. Overall risk of distant metastasis was lower in IP-SCC. DN-SCC, compared to IP-SCC, is more likely to present with advanced TNM classification and have positive margins after surgical resection, which may affect rates of distant metastasis and recurrence.

CONCLUSIONS:

The findings in this study suggest IP-SCC may be a less aggressive malignancy compared to DN-SCC, with the possibility of a reduced role for adjuvant therapy in IP-SCC. Further studies are required to better understand differences in tumor biology and treatments strategies between IP-SCC and DN-SCC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Seios Paranasais / Carcinoma de Células Escamosas / Neoplasias Nasais / Papiloma Invertido Tipo de estudo: Observational_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Rhinology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Seios Paranasais / Carcinoma de Células Escamosas / Neoplasias Nasais / Papiloma Invertido Tipo de estudo: Observational_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Rhinology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos